Giant mantle cell lymphoma in the soft tissue of the leg: rare presentation.


Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 23 3 2021
medline: 15 12 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

Mantle cell lymphomas are aggressive, mature B-cell neoplasms characteristically showing overexpression of cyclin D1. Although lymphadenopathy is the most common presentation, involvement of extranodal sites including bone marrow, peripheral blood, liver, gastrointestinal system, and Waldeyer ring is also seen frequently. Soft tissue localization is extremely rare. It has blastoid and pleomorphic subtypes associated with aggressive course. We describe a 74-year-old man who had been diagnosed 3 years previously with "mantle cell lymphoma-blastoid type" and presented 3 months ago with a giant mass in the right lower extremity that enlarged rapidly up to 15 cm in a few months. We present this rare presentation, which was evaluated in favor of hemangioma before biopsy, together with the data in the literature to emphasize the need for differential diagnosis, especially in cases with a clinical history.

Sections du résumé

BACKGROUND BACKGROUND
Mantle cell lymphomas are aggressive, mature B-cell neoplasms characteristically showing overexpression of cyclin D1. Although lymphadenopathy is the most common presentation, involvement of extranodal sites including bone marrow, peripheral blood, liver, gastrointestinal system, and Waldeyer ring is also seen frequently. Soft tissue localization is extremely rare. It has blastoid and pleomorphic subtypes associated with aggressive course.
CASE DESCRIPTION METHODS
We describe a 74-year-old man who had been diagnosed 3 years previously with "mantle cell lymphoma-blastoid type" and presented 3 months ago with a giant mass in the right lower extremity that enlarged rapidly up to 15 cm in a few months.
CONCLUSION CONCLUSIONS
We present this rare presentation, which was evaluated in favor of hemangioma before biopsy, together with the data in the literature to emphasize the need for differential diagnosis, especially in cases with a clinical history.

Identifiants

pubmed: 33745393
doi: 10.1177/03008916211001925
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

NP49-NP53

Auteurs

Büşra Erşan Erdem (BE)

Faculty of Medicine, Department of Pathology, Kocaeli University, Kocaeli, Turkey.

Umay Kiraz (U)

Faculty of Medicine, Department of Pathology, Kocaeli University, Kocaeli, Turkey.

Çiğdem Vural (Ç)

Faculty of Medicine, Department of Pathology, Kocaeli University, Kocaeli, Turkey.

Halil Atmaca (H)

Faculty of Health Sciences, Orthopaedics and Traumatology, Final International University, Kyrenia, TRNC, Girne, Cyprus.

Ahmet Tuğrul Eruyar (AT)

Faculty of Medicine, Department of Pathology, Kocaeli University, Kocaeli, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH